Exabis Library
Welcome to the e-CCO Library!
P0696: ADSS: A novel AI-derived metric for quantifying disease severity and extent in ulcerative colitis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0697: Ozanimod Inhibits Pro-Inflammatory Mediators of the IL-17 Pathway in the Tissues of Participants in the Phase 2 TOUCHSTONE Study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0698: Early faecal calprotectin predicts clinical outcomes in Acute Severe Ulcerative Colitis: results from PREDICT-UC
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0699: Comparative Effectiveness and Safety of Denosumab Versus Bisphosphonates in Osteoporosis Management Among Patients with Inflammatory Bowel Disease: A U.S. Propensity Matched Cohort Study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P069: Artificial intelligence (AI)-filtered Videos for Accelerated Scoring of Colonoscopy Videos in Ulcerative Colitis Clinical Trials
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P069: Design and delivery of anti-oxidant inorganic complexes mimicking the superoxide dismutase for inflammatory bowel diseases treatment.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P069: Elevated adaptive immune responses to multiple Lachnospiraceae bacterial flagellins in therapy-naïve pediatric CD patients are associated with distinct immune pathology.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P069: Intraperitoneal injection of bone marrow derived-mesenchymal stem cells increases total number of colon-infiltrating inflammatory dendritic cells and macrophages and aggravates colitis in BALBc mice
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P069: New methylation biomarker panel of inflammatory Mucosa in Korean Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P069: Sympathetic but not vagal intestinal innervation regulates murine dextran sodium sulphate-induced colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P069: TD-1473, a novel, potent, and orally administered, GI-targeted, pan-Janus kinase (JAK) inhibitor
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P070 Machine learning approaches to identify IBD biomarkers from longitudinal microbiome data
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P0700: Impact of filgotinib on health-related quality of life over 3 years in Japanese patients with Ulcerative Colitis: A post hoc analysis of the SELECTION and SELECTION long-term extension trials
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0701: Trans-continental analysis of determinants of response to COVID-19 vaccination in 2268 patients with Inflammatory Bowel Disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0702: Efficacy of subcutaneous infliximab maintenance therapy according to disease location in patients with moderate-to-severe Crohn’s disease: A post hoc analysis of the Phase 3 LIBERTY-CD study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0703: Risk factors and nomogram for massive postoperative gastrointestinal bleeding in patients with Crohn's disease: a multicenter retrospective study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0704: A Multicenter Study Evaluating the Persistencex7x7x7 Effectivenessx7x7x7 and Safety of Methotrexate in Patients with Inflammatory Bowel Disease: The MICI-METHO Study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0705: Features of optimal disease control in Crohn’s disease and Ulcerative Colitis: Views on IBD Expectations and Well-being by Patients and Treatment providers
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0706: Dose intensification of subcutaneous vedolizumab is an effective and safe option in Inflammatory Bowel Disease patients: Results from the multicentre OPTI-VEDO study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0707: Impact of age of disease diagnosis on disease phenotype and severity in patients with Inflammatory Bowel Diseases
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM